These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36301125)

  • 41. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
    Wahidiyat PA; Iskandar SD; Sekarsari D
    Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements.
    Papakonstantinou O; Kostaridou S; Maris T; Gouliamos A; Premetis E; Kouloulias V; Nakopoulou L; Kattamis C
    J Pediatr Hematol Oncol; 1999; 21(2):142-8. PubMed ID: 10206461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cirrhosis associated with multiple transfusions in thalassaemia.
    Jean G; Terzoli S; Mauri R; Borghetti L; Di Palma A; Piga A; Magliano M; Melevendi M; Cattaneo M
    Arch Dis Child; 1984 Jan; 59(1):67-70. PubMed ID: 6696498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications.
    El-Asrar MA; Elbarbary NS; Ismail EA; Elshenity AM
    Blood Cells Mol Dis; 2016 Jan; 56(1):1-8. PubMed ID: 26603717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia.
    Chang HH; Chen MJ; Lu MY; Chern JP; Lu CY; Yang YL; Jou ST; Lin DT; Yang YS; Lin KH
    BJOG; 2011 Jun; 118(7):825-31. PubMed ID: 21401854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
    Ricchi P; Meloni A; Spasiano A; Neri MG; Gamberini MR; Cuccia L; Caruso V; Gerardi C; D'Ascola DG; Rosso R; Campisi S; Rizzo M; Terrazzino F; Vangosa AB; Chiodi E; Missere M; Mangione M; Positano V; Pepe A
    Am J Hematol; 2015 Nov; 90(11):1008-12. PubMed ID: 26228763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe Iron Overload.
    Izzy M; Kamath PS
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):A28. PubMed ID: 30120996
    [No Abstract]   [Full Text] [Related]  

  • 49. ADAMTS13 Levels in Young Patients With β-Thalassemia Major: Relation to Hepatitis C Virus Infection, Liver Cirrhosis, and Iron Overload.
    Hamed AA; Darwish YW; El-Sayed MH
    Clin Appl Thromb Hemost; 2015 Sep; 21(6):527-32. PubMed ID: 25430937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload.
    Elalfy MS; Saber MM; Adly AA; Ismail EA; Tarif M; Ibrahim F; Elalfy OM
    Eur J Haematol; 2016 Mar; 96(3):318-26. PubMed ID: 26018112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma in the thalassaemia syndromes.
    Borgna-Pignatti C; Vergine G; Lombardo T; Cappellini MD; Cianciulli P; Maggio A; Renda D; Lai ME; Mandas A; Forni G; Piga A; Bisconte MG
    Br J Haematol; 2004 Jan; 124(1):114-7. PubMed ID: 14675416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography.
    Al-Khabori M; Daar S; Al-Busafi SA; Al-Dhuhli H; Alumairi AA; Hassan M; Al-Rahbi S; Al-Ajmi U
    Hematology; 2019 Dec; 24(1):183-188. PubMed ID: 30453843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.
    Deugnier Y; Turlin B; Ropert M; Cappellini MD; Porter JB; Giannone V; Zhang Y; Griffel L; Brissot P
    Gastroenterology; 2011 Oct; 141(4):1202-11, 1211.e1-3. PubMed ID: 21741344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major.
    Wood JC; Claster S; Carson S; Menteer JD; Hofstra T; Khanna R; Coates T
    Br J Haematol; 2008 Jun; 141(6):891-4. PubMed ID: 18371108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major.
    Casale M; Marsella M; Ammirabile M; Spasiano A; Costantini S; Cinque P; Ricchi P; Filosa A
    Blood Transfus; 2019 May; 17(3):165-170. PubMed ID: 30036179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients.
    Tangvarasittichai S; Pimanprom A; Choowet A; Tangvarasittichai O
    Clin Lab; 2013; 59(7-8):861-8. PubMed ID: 24133917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: A randomized double-blind placebo-controlled trial.
    Gupta V; Kumar I; Raj V; Aggarwal P; Agrawal V
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29564. PubMed ID: 35092347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pituitary Iron Deposition and Endocrine Complications in Patients with β-Thalassemia: From Childhood to Adulthood.
    Karadag SIK; Karakas Z; Yilmaz Y; Gul N; Demir AA; Bayramoglu Z; Darendeliler F; Dursun M
    Hemoglobin; 2020 Sep; 44(5):344-348. PubMed ID: 32900239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.